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simple Bayesian form of analysis, 69%
accuracy overall was achieved in predicting
survival time (with 80% accuracy in those
patients who survived over 2 months) and
accuracy in predicting an objective response
was 82%, and 72% for a subjective response.
These results suggest that: (i) it is possible
in most patients to predict response using
simple clinical parameters and analysis; (ii)
this can be done in routine practice quickly
and easily; and (iii) such a system-if
implemented widely-might be of significant
benefit to individual women suffering from
breast cancer.
p-FLUOROPHENYLALANINE (pFPhe)
AND MITOSIS: INHIBITION AND
RECOVERY OF DIVISION IN HELA
CELLS. D. N. WHEATLEY AND J. Y.
HENDERSON. Department of Pathology,
University of Aberdeen.
pFPhe inhibits the entry of HeLa cells
into division; this effect is known to require
incorporation ofthe amino-acid analogue into
protein (Wheatley and Henderson, Nature,
Lond., 1974, 247, 281). Analysis of the
proteins containing pFPhe made by HeLa
cells on polyacrylamide disc gel electro-
phoresis systems showed excellent agreement
with the Phe proteins. The turnover of
pFPhe proteins also compared closely with
that of the Phe proteins both at 37°C and
400C.
When pFPhe is removed from the culture
medium, cells recover their normal G2 -÷ M
progression in a cycle related manner after a
delay period which depends on both the
concentration and length ofpFPhe exposure.
After careful analysis of conditions per-
mitting recovery, it would appear that a
highly labile protein or group of proteins is
involved which can only suppress mitosis
when pFPhe is maintained at " physio-
logical" levels. At slightly elevated tem-
perature the inhibitory action is accentuated.
A COMPARISON OF CHEMICAL
AND MICROBIOLOGICAL METHODS
FOR ESTIMATING ALKYLATING
AGENT CONCENTRATION. S. M.
ToOGOOD, P. WORKMAN, C. R. BALL and
R. C. GARNER. Department of Cancer
Research, University of Leeds.
Three methods of estimating alkylating
agent concentration have been compared,
initially using aniline mustard as a model
compound: (i) inactivation of E. coli B; (ii)
reaction with 4-p-nitrobenzyl pyridine
(Epstein et al., Anal. Chem., 1955, 27, 1435)
and (iii) formation ofa 35S-thiazan derivative
(Connors, T. A. et al., Biochem. Pharmac.,
1972, 21, 1309).
Quantitation ofthelatterin areproducible
manner has proved difficult and sensitivity is
not as great as expected. Greatest biological
sensitivity amongst DNA repair deficient
strains of E. coli B was shown by uvrA
exrA and uvrA recA mutants. Surprisingly,
a triple mutant polAuvrAexrA was less
sensitive to both aniline and nitrogen
mustards, the reverse being true for methyl
methane sulphonate.
The microbiological method is more
sensitive than either chemical method, parti-
cularly for the more reactive drugs such as
p-hydroxyaniline mustard and nitrogen mus-
tard, and more readily applied in some
instances. The method has enabled drug
adsorption to albumin to be studied. Identi-
fication and estimation of alkylating agents
and their metabolites in biological fluids
should be made possible using this technique.
PREDICTION OF RESPONSE TO
ANTIHORMONE TREATMENT US-
ING AN IN VITRO TEST FOR DE-
PENDENCE OF HORMONES. H.
SALIH, I. DE SOUZA, H. FLAX, K. NEWTON
and J. R. HOBBS. Tumour Biology Group,
Westminster Hospital Medical School.
In vitro hormone dependence has been
defined by detecting enhanced pentose shunt
activity in 24 h cultures of freshly biopsied
human breast cancers after known hormones
have been added to the culture medium.
Four hormones (oestrogen, androgen, pro-
lactin, growth hormone) have been implicated
in half of the 300 breast cancers, and these
could not be assessed adequately by the
previous methods ofstudyingurinarypatterns
ofandrogen excretion or measuring binding to
receptors in homogenates. The clinical
response of 40 patients to antihormonal
treatments revealed: (1) 9/9 oestrogen depen-
dent tumours responding to antioestrogens;
(2) 6/7 androgen dependent tumours respond-
ing to antiandrogenic measures; (3) 5/6
prolactin - growth hormone dependent
tumours responding to satisfactory hypo-
physectomy; (4) 3/3 prolactin dependent